JAMA Network Home
Sign In
Viewpoint

Modernizing Surrogate Decision-Making to Reflect the Complexity of Cancer Care

JAMA Oncology 10.1001/jamaoncol.2026.3319

September 10, 2026 at 11:00 AM EDT

Read the full article

This Viewpoint promotes surrogate decision-making based on patient process preferences that allows surrogate decision-makers and clinicians to make decisions in a manner that is adaptable to evolving cancer therapies and respects the values of patients.

Corresponding Author: Gregory A. Abel, MD, MPH, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 (gregory_abel@dfci.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.3319?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091026

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks